TM4SF1 and ovarian cancer: High expression of TM4SF1 predicted a poor prognosis in patients with glioma, colorectal cancer, breast cancer, papillary thyroid carcinomas and ovarian cancer but predicted good prognosis in GC, pancreatic cancer, breast cancer and MPM.